Diffusion-weighted magnetic resonance for pulmonary nodules: 1.5 vs. 3 Tesla

Asian Cardiovascular and Thoracic Annals

Volumn 19, Issue 2, 2011, Pages 108-114

  Ohba, Yasuomi ^a   Nomori, Hiroaki ^a,b   Mori, Takeshi ^a   Shiraishi, Kenji ^a   Namimoto, Tomohiro ^a   Katahira, Kazuhiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Carcinoma; Diffusion magnetic resonance imaging; Emission computed; Fluorodeoxyglucose F18; Lung neoplasms; Non small cell lung; Single photon; Tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HUMAN; LUNG NODULE; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; LUNG DISEASES; LUNG NEOPLASMS; MULTIPLE PULMONARY NODULES; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SOLITARY PULMONARY NODULE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79956040267     PISSN: 02184923     EISSN: 02184923     Source Type: Journal    
DOI: 10.1177/0218492310385152     Document Type: Article

References (20)

1. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis e and Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion neurogenic disorders. Radiology 1986;161:401-407. (Pubitemid 17173295)
2. Sumi M, Takagi Y, Uetani M, Morikawa M, Hayashi K, Kabasawa H, et al. Diffusion-weighted echoplanar MR imaging of salivary glands. AJR Am J Roentgenol 2002;178:959-965. (Pubitemid 34250239)
3. Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, et al. Head and Neck lesions: characterization with diffusion-weighted echoplanar MR imaging. Radiology 2001;220:621-630. (Pubitemid 32799967)
4. Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S and Endo Y. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol 2008;191:464-470.
5. Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, et al. ADC Mapping of Benign and Malignant Breast Tumors. Magn Reson Med Sci 2005;4:35-42.
6. Baur A and Reiser MF. Diffusion-weighted imaging of musculoskeletal system in humans [Review]. Skeletal Radiol 2000;29:555-562.
7. Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, et al. Combined use of diffusionweighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007;188:91-98. (Pubitemid 46012494)
8. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002;360:307-308. (Pubitemid 34874724)
9. Mori T, Nomori H, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, et al. Diffusion-weighted magnetic resonance imaging in comparison with positron emission tomography for pulmonary nodules. J Thorac Oncol 2008;3:358-364. (Pubitemid 351489475)
10. Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg 2008;135:816-822. (Pubitemid 351417933)
11. Ohba Y, Nomori H, Mori T, Ikeda K, Shibata H, Kobayashi H, et al. Is diffusion-weighted magnetic resonance imaging superior to fluorodeoxyglucose- positron emission tomography in non-small cell lung cancer? J Thorac Cardiovasc Surg 2009;138:439-445.
12. Seo HS, Chang KH, Na DG, Kwon BJ and Lee DH. High b-value diffusion (b=3000 s/mm2) MR imaging in cerebral gliomas at 3T: visual and quantitative comparisons with b=1000 s/mm2. Am J Neuroradiol 2008;29:458-463. (Pubitemid 351424057)
13. Naganawa S, Kawai H, Fukatsu H, Sakurai Y, Aoki I, Miura S, et al. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 2005;4:175-186.
14. Koh DM and Padhani AR. Diffusion-weighted MRI: a new functional clinical technique for tumor imaging. Br J Radiol 2006;79:633-635. (Pubitemid 44283151)
15. Ohba Y, Nomori H, Shibata H, Kobayashi H, Mori T, Shiraishi S, et al. Evaluation of semiquantitative assessments of fluorodeoxyglucose uptake on positron emission tomography scans for the diagnosis of pulmonary malignancies 1 to 3cm in Size. Ann Thorac Surg 2009;87:886-891.
16. Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, et al. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med 1998;39:1727-1735. (Pubitemid 28473521)
17. Kim CK, Gupta NC, Chandramouli B and Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med 1994;35:164-167. (Pubitemid 24018461)
18. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U and Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer-a PET study. J Nucl Med 1993;34:1-6. (Pubitemid 23014212)
19. Bernstein MA, Huston 3rd J, Lin C, Gibbs GF and Felmlee JP. High-resolution intracranial and cervical MRA at 3.0T: technical considerations and initial experience. Mgn Reson Med 2001;46:955-962. (Pubitemid 33019920)
20. Fushimi Y, Miki Y, Kikuta K, Okada T, Kanagaki M, Yamamoto A, et al. Comparison of 3.0-T and 1.5-T three-dimensional time-of-flight MR angiography in Moyamoya disease: preliminary experience. Radiology 2006;239:232-237.